RECRUITING

Time Restricted Eating (TRE) Among Endometrial Cancer Patients

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The long-term goal of this study is to determine the efficacy of Time Restricted Eating (TRE) for improving metabolic health, preventing cardiometabolic comorbidities, and improving prognosis after endometrial cancer diagnosis. The primary objective of the protocol is to conduct a 16-week randomized dietary crossover study to evaluate the feasibility, fidelity and preliminary acceptability of TRE among endometrial cancer patients, and to provide proof of principle that TRE can improve metabolic health in this population.

Official Title

Feasibility and Acceptability of Time Restricted Eating (TRE) Among Endometrial Cancer Patients: the TREND Study

Quick Facts

Study Start:2021-10-07
Study Completion:2024-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04783467

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Females aged 18 years or older
  2. * Diagnosed with endometrial cancer (any stage)
  3. * Clinically overweight or obese (BMI \>= 25 kg/m2)
  4. * At least 3 months post-cancer surgery and/or treatment
  5. * Weight stable for 3 months prior to beginning the study (\<4kg weight loss/gain)
  6. * Have a cell phone that is able to download a phone App and able to use phone during the day
  1. * Persons with special dietary requirements
  2. * Unable to provide informed consent
  3. * Unable to read, write, or fill in questionnaires in English
  4. * Insulin dependent diabetes
  5. * Night shift workers
  6. * Persons not able to use cell phone during day (like for work)

Contacts and Locations

Study Contact

Mary Playdon, PhD, MPH
CONTACT
(801) 213-6264
mary.playdon@hci.utah.edu

Principal Investigator

Mary Playdon, PhD, MPH
PRINCIPAL_INVESTIGATOR
University of Utah

Study Locations (Sites)

Huntsman Cancer Institute
Salt Lake City, Utah, 84112
United States

Collaborators and Investigators

Sponsor: University of Utah

  • Mary Playdon, PhD, MPH, PRINCIPAL_INVESTIGATOR, University of Utah

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-10-07
Study Completion Date2024-06

Study Record Updates

Study Start Date2021-10-07
Study Completion Date2024-06

Terms related to this study

Additional Relevant MeSH Terms

  • Endometrial Cancer